Log In
Print
BCIQ
Print
Print this Print this
 

LY2405319

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionFibroblast growth factor 21 (FGF21) variant
Molecular Target Fibroblast growth factor 21 (FGF21)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes in obese patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today